WASHINGTON, June 4 (Reuters) - Commonwealth Fusion Systems, the world's top-funded private firm among those seeking to generate power by replicating the nuclear reaction that takes place in stars, ...

Spoiler alert! We're talking aboutthe biggest reveals in "Backrooms" (in theaters now) and the movie's ending, so turn away if you haven't seen it yet. The world of "Backrooms" isn't done expanding.

The Backrooms movie will be released in theaters on May 29. Liminal spaces – dreamy and nostalgic locales defined by their specific use as a transient space that you don’t spend much time in but ...

When you're onboard what is essentially a massive floating city, isolated in the middle of the ocean, logistics like resupply can be a massive nightmare. Refueling is also staggeringly expensive. A ...

Discover What’s Streaming On: The set-up of APEX—the new Charlize Theron Netflix movie that began streaming today—is simple. Taron Egerton is a deranged killer, and Charlize Theron has to outrun him ...

The Vampire Crawlers: The Turbo Wildcard from Vampire Survivors' combo system is the most powerful feature in the game, yet it's easily overlooked. If you play your cards in a certain order, you will ...

A solar generator’s capacity is measured in watt-hours, and it can give you an idea of how long you can power devices. Higher-powered devices eat up more capacity, thus draining the battery faster.

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...